- Home
- Publications
- Publication Search
- Publication Details
Title
Tofacitinib for the treatment of rheumatoid arthritis: an update
Authors
Keywords
-
Journal
Expert Review of Clinical Immunology
Volume 15, Issue 6, Pages 577-588
Publisher
Informa UK Limited
Online
2019-04-19
DOI
10.1080/1744666x.2019.1607298
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative Risk of Cardiovascular Events with Biologic and Synthetic Disease‐Modifying Anti‐Rheumatic Drugs in Patients with Rheumatoid Arthritis: A Systematic Review and Meta‐analysis
- (2019) Siddharth Singh et al. ARTHRITIS CARE & RESEARCH
- Tofacitinib in steroid-dependent relapsing polychondritis
- (2018) Alexey D Meshkov et al. ANNALS OF THE RHEUMATIC DISEASES
- Tofacitinib in patients with moderate to severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study
- (2018) F. Valenzuela et al. BRITISH JOURNAL OF DERMATOLOGY
- The Impact of Biologics and Tofacitinib on Cardiovascular Risk Factors and Outcomes in Patients with Rheumatic Disease: A Systematic Literature Review
- (2018) Michael Nurmohamed et al. DRUG SAFETY
- Tofacitinib Therapy for Rheumatoid Arthritis: A Direct Comparison Study between Biologic-naïve and Experienced Patients
- (2018) Shunsuke Mori et al. INTERNAL MEDICINE
- Tofacitinib with conventional synthetic disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient-reported outcomes from a Phase 3 randomized controlled trial
- (2018) Zhanguo Li et al. International Journal of Rheumatic Diseases
- The clinical course of patients with rheumatoid arthritis who underwent orthopaedic surgeries under disease control by tofacitinib
- (2018) Keiichiro Nishida et al. Modern Rheumatology
- A pooled analysis of the safety of tofacitinib as monotherapy or in combination with background conventional synthetic disease-modifying antirheumatic drugs in a Phase 3 rheumatoid arthritis population
- (2018) Alan J. Kivitz et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Lymphoma in the Tofacitinib Rheumatoid Arthritis Clinical Development Program
- (2018) Xavier Mariette et al. ARTHRITIS CARE & RESEARCH
- Sustained Response Following Discontinuation of Methotrexate in Patients With Rheumatoid Arthritis Treated With Subcutaneous Tocilizumab
- (2018) Joel M. Kremer et al. Arthritis & Rheumatology
- Tumor Necrosis Factor Inhibitors and Cancer Recurrence in Swedish Patients With Rheumatoid Arthritis
- (2018) Pauline Raaschou et al. ANNALS OF INTERNAL MEDICINE
- Tofacitinib as the potent treatment for refractory pemphigus: A possible alternative treatment for pemphigus
- (2018) Soheil Tavakolpour Dermatologic Therapy
- Tofacitinib for the treatment of lichen planopilaris: A case series
- (2018) Christine C. Yang et al. Dermatologic Therapy
- Tofacitinib, an oral Janus kinase inhibitor, in patients from Brazil with rheumatoid arthritis
- (2018) Andrea B.V. Lomonte et al. MEDICINE
- Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis
- (2018) William Damsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Herpes Zoster in Tofacitinib: Risk is Further Increased with Glucocorticoids but not Methotrexate
- (2018) Jeffrey R Curtis et al. ARTHRITIS CARE & RESEARCH
- 2483. Twelve-Month Immunogenicity and Safety of an Adjuvanted Recombinant Zoster Vaccine in Immunosuppressed Adults Post Renal Transplant: a Phase III Randomized Clinical Trial
- (2018) Peter Vink et al. Open Forum Infectious Diseases
- Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies
- (2017) Christina Charles-Schoeman et al. JOURNAL OF RHEUMATOLOGY
- Discontinuation of tofacitinib after achieving low disease activity in patients with rheumatoid arthritis: a multicentre, observational study
- (2017) Satoshi Kubo et al. RHEUMATOLOGY
- Outcomes after rheumatoid arthritis patients complete their participation in a long-term observational study with tofacitinib combined with methotrexate: practical and ethical implications in vulnerable populations after tofacitinib discontinuation
- (2017) Diana I. Pérez-Román et al. RHEUMATOLOGY INTERNATIONAL
- A cytokine signal inhibitor for rheumatoid arthritis enhances cancer metastasis via depletion of NK cells in an experimental lung metastasis mouse model of colon cancer
- (2017) Hideki Shimaoka et al. Oncology Letters
- The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial
- (2017) Kevin L. Winthrop et al. Arthritis & Rheumatology
- Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy
- (2017) Kevin L. Winthrop et al. Arthritis & Rheumatology
- Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis
- (2017) Naoki Iwamoto et al. PLoS One
- Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis
- (2016) Jeffrey R Curtis et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group
- (2016) R Fleischmann et al. CLINICAL RHEUMATOLOGY
- Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster
- (2016) Kunihiro Yamaoka DRUG SAFETY
- Metabolic changes modify Treg cell function
- (2016) Sarah Onuora Nature Reviews Rheumatology
- Type I/II cytokines, JAKs and new strategies for treating autoimmune diseases
- (2015) Daniella M. Schwartz et al. Nature Reviews Rheumatology
- Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
- (2015) Himal Lal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial
- (2014) Gerd-Rűdiger Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
- (2014) Takao Koike et al. Modern Rheumatology
- Effects of tofacitinib on lymphocytes in rheumatoid arthritis: relation to efficacy and infectious adverse events
- (2014) Koshiro Sonomoto et al. RHEUMATOLOGY
- Effects of Fostamatinib (R788), an Oral Spleen Tyrosine Kinase Inhibitor, on Health-related Quality of Life in Patients with Active Rheumatoid Arthritis: Analyses of Patient-reported Outcomes from a Randomized, Double-blind, Placebo-controlled Trial
- (2013) M. E. Weinblatt et al. JOURNAL OF RHEUMATOLOGY
- Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan
- (2013) T. Koike et al. JOURNAL OF RHEUMATOLOGY
- Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: Postmarketing surveillance report of 7740 patients
- (2013) Takao Koike et al. Modern Rheumatology
- Forget personalised medicine and focus on abating disease activity
- (2012) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
- (2012) Roy Fleischmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells
- (2011) Keisuke Maeshima et al. ARTHRITIS AND RHEUMATISM
- Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response: Subanalysis of the PREMIER study
- (2011) Mari Hoff et al. BMC MUSCULOSKELETAL DISORDERS
- A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of Oral SCIO-469, a p38 Mitogen-activated Protein Kinase Inhibitor, in Patients with Active Rheumatoid Arthritis
- (2011) MARK C. GENOVESE et al. JOURNAL OF RHEUMATOLOGY
- An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis
- (2010) Michael E. Weinblatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative effectiveness of tumour necrosis factor inhibitors in combination with either methotrexate or leflunomide
- (2009) A Strangfeld et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: Results of two randomized, double-blind, placebo-controlled clinical studies
- (2009) Nemanja Damjanov et al. ARTHRITIS AND RHEUMATISM
- Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study
- (2008) M Hoff et al. ANNALS OF THE RHEUMATIC DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started